BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29330337)

  • 1. Role of germline aberrations affecting
    Weren RDA; van der Post RS; Vogelaar IP; van Krieken JH; Spruijt L; Lubinski J; Jakubowska A; Teodorczyk U; Aalfs CM; van Hest LP; Oliveira C; Kamping EJ; Schackert HK; Ranzani GN; Gómez García EB; Hes FJ; Holinski-Feder E; Genuardi M; Ausems MGEM; Sijmons RH; Wagner A; van der Kolk LE; Cats A; Bjørnevoll I; Hoogerbrugge N; Ligtenberg MJL
    J Med Genet; 2018 Oct; 55(10):669-674. PubMed ID: 29330337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline mutations in MAP3K6 are associated with familial gastric cancer.
    Gaston D; Hansford S; Oliveira C; Nightingale M; Pinheiro H; Macgillivray C; Kaurah P; Rideout AL; Steele P; Soares G; Huang WY; Whitehouse S; Blowers S; LeBlanc MA; Jiang H; Greer W; Samuels ME; Orr A; Fernandez CV; Majewski J; Ludman M; Dyack S; Penney LS; McMaster CR; Huntsman D; Bedard K
    PLoS Genet; 2014 Oct; 10(10):e1004669. PubMed ID: 25340522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer predisposition and germline CTNNA1 variants.
    Lobo S; Benusiglio PR; Coulet F; Boussemart L; Golmard L; Spier I; Hüneburg R; Aretz S; Colas C; Oliveira C
    Eur J Med Genet; 2021 Oct; 64(10):104316. PubMed ID: 34425242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An α-E-catenin (CTNNA1) mutation in hereditary diffuse gastric cancer.
    Majewski IJ; Kluijt I; Cats A; Scerri TS; de Jong D; Kluin RJ; Hansford S; Hogervorst FB; Bosma AJ; Hofland I; Winter M; Huntsman D; Jonkers J; Bahlo M; Bernards R
    J Pathol; 2013 Mar; 229(4):621-9. PubMed ID: 23208944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exome sequencing reveals three novel candidate predisposition genes for diffuse gastric cancer.
    Donner I; Kiviluoto T; Ristimäki A; Aaltonen LA; Vahteristo P
    Fam Cancer; 2015 Jun; 14(2):241-6. PubMed ID: 25576241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic predisposition to gastric cancer.
    Petrovchich I; Ford JM
    Semin Oncol; 2016 Oct; 43(5):554-559. PubMed ID: 27899187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implications of CTNNA1 germline mutations in asymptomatic carriers.
    Benusiglio PR; Colas C; Guillerm E; Canard A; Delhomelle H; Warcoin M; Bellanger J; Eyries M; Zizi M; Netter J; Soubrier F; Parc Y; Mourregot A; Maran Gonzalez A; Cusin V; Denis JA; Coupier I; Svrcek M; Coulet F
    Gastric Cancer; 2019 Jul; 22(4):899-903. PubMed ID: 30515673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline CDH1 mutations are a significant contributor to the high frequency of early-onset diffuse gastric cancer cases in New Zealand Māori.
    Hakkaart C; Ellison-Loschmann L; Day R; Sporle A; Koea J; Harawira P; Cheng S; Gray M; Whaanga T; Pearce N; Guilford P
    Fam Cancer; 2019 Jan; 18(1):83-90. PubMed ID: 29589180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unraveling genetic predisposition to familial or early onset gastric cancer using germline whole-exome sequencing.
    Vogelaar IP; van der Post RS; van Krieken JHJ; Spruijt L; van Zelst-Stams WA; Kets CM; Lubinski J; Jakubowska A; Teodorczyk U; Aalfs CM; van Hest LP; Pinheiro H; Oliveira C; Jhangiani SN; Muzny DM; Gibbs RA; Lupski JR; de Ligt J; Vissers LELM; Hoischen A; Gilissen C; van de Vorst M; Goeman JJ; Schackert HK; Ranzani GN; Molinaro V; Gómez García EB; Hes FJ; Holinski-Feder E; Genuardi M; Ausems MGEM; Sijmons RH; Wagner A; van der Kolk LE; Bjørnevoll I; Høberg-Vetti H; van Kessel AG; Kuiper RP; Ligtenberg MJL; Hoogerbrugge N
    Eur J Hum Genet; 2017 Nov; 25(11):1246-1252. PubMed ID: 28875981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary diffuse gastric cancer - pathophysiology and clinical management.
    Pinheiro H; Oliveira C; Seruca R; Carneiro F
    Best Pract Res Clin Gastroenterol; 2014 Dec; 28(6):1055-68. PubMed ID: 25439071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First estimates of diffuse gastric cancer risks for carriers of
    Coudert M; Drouet Y; Delhomelle H; Svrcek M; Benusiglio PR; Coulet F; Clark DF; Katona BW; van Hest LP; van der Kolk LE; Cats A; van Dieren JM; Nehoray B; Slavin T; Spier I; Hüneburg R; Lobo S; Oliveira C; Boussemart L; Masson L; Chiesa J; Schwartz M; Buecher B; Golmard L; Bouvier AM; Bonadona V; Stoppa-Lyonnet D; Lasset C; Colas C
    J Med Genet; 2022 Dec; 59(12):1189-1195. PubMed ID: 36038258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer.
    Adib E; El Zarif T; Nassar AH; Akl EW; Abou Alaiwi S; Mouhieddine TH; Esplin ED; Hatchell K; Nielsen SM; Rana HQ; Choueiri TK; Kwiatkowski DJ; Sonpavde G
    Br J Cancer; 2022 Mar; 126(5):797-803. PubMed ID: 34949788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catenin family genes are not commonly mutated in hereditary diffuse gastric cancer.
    Schuetz JM; Leach S; Kaurah P; Jeyes J; Butterfield Y; Huntsman D; Brooks-Wilson AR
    Cancer Epidemiol Biomarkers Prev; 2012 Dec; 21(12):2272-4. PubMed ID: 23071139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of CDH1 germline variants in sporadic gastric cancer patients and in individuals at risk of gastric cancer.
    Garziera M; Canzonieri V; Cannizzaro R; Geremia S; Caggiari L; De Zorzi M; Maiero S; Orzes E; Perin T; Zanussi S; De Paoli P; De Re V
    PLoS One; 2013; 8(10):e77035. PubMed ID: 24204729
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Ben Aissa-Haj J; Kabbage M; Othmen H; Saulnier P; Kettiti HT; Jaballah-Gabteni A; Ferah A; Medhioub M; Khsiba A; Mahmoudi M; Maaloul A; Ben Nasr S; Chelbi E; Abdelhak S; Boubaker MS; Azzouz MM; Rouleau E
    Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic Germline Mutations in Chinese Patients with Gastric Cancer Identified by Next-Generation Sequencing.
    Zhou J; Zhao Z; Zhang Y; Bao C; Cui L; Cai S; Bai Y; Shen L; Zhang X
    Oncology; 2020; 98(8):583-588. PubMed ID: 32521533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of New Genes Involved in Germline Predisposition to Early-Onset Gastric Cancer.
    Herrera-Pariente C; Capó-García R; Díaz-Gay M; Carballal S; Muñoz J; Llach J; Sánchez A; Bonjoch L; Arnau-Collell C; Soares de Lima Y; Golubicki M; Jung G; Lozano JJ; Castells A; Balaguer F; Bujanda L; Castellví-Bel S; Moreira L
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDH1 mutations in gastric cancers are not associated with family history.
    Choi S; Jang J; Heo YJ; Kang SY; Kim ST; Lee J; Kang WK; Kim JW; Kim KM
    Pathol Res Pract; 2020 May; 216(5):152941. PubMed ID: 32241597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition of and recent issues in hereditary diffuse gastric cancer.
    Sugimoto S; Komatsu H; Morohoshi Y; Kanai T
    J Gastroenterol; 2015 Aug; 50(8):831-43. PubMed ID: 26049741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric cancer: new genetic developments.
    Lynch HT; Grady W; Suriano G; Huntsman D
    J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.